These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9226103)

  • 61. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Continued thromboxane A2 formation despite administration of a platelet glycoprotein IIb/IIIa antagonist in patients undergoing coronary angioplasty.
    Byrne A; Moran N; Maher M; Walsh N; Crean P; Fitzgerald DJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3224-9. PubMed ID: 9409315
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CGS 12970: a novel, long acting thromboxane synthetase inhibitor.
    Ambler J; Butler KD; Ku EC; Maguire ED; Smith JR; Wallis RB
    Br J Pharmacol; 1985 Oct; 86(2):497-504. PubMed ID: 2932197
    [TBL] [Abstract][Full Text] [Related]  

  • 64. ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro.
    Brownlie RP; Brownrigg NJ; Butcher HM; Garcia R; Jessup R; Lee VJ; Tunstall S; Wayne MG
    Br J Pharmacol; 1993 Dec; 110(4):1600-6. PubMed ID: 8306107
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The novel thromboxane A2 receptor antagonist KW-3635 reduces infarct size in a canine model of coronary occlusion and reperfusion.
    Higo K; Sano J; Karasawa A; Kubo K
    Arch Int Pharmacodyn Ther; 1993; 323():32-49. PubMed ID: 8250642
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.
    Hennan JK; Huang J; Barrett TD; Driscoll EM; Willens DE; Park AM; Crofford LJ; Lucchesi BR
    Circulation; 2001 Aug; 104(7):820-5. PubMed ID: 11502709
    [TBL] [Abstract][Full Text] [Related]  

  • 67. On the bioisosteric potential of diazines: diazine analogues of the combined thromboxane A2 receptor antagonist and synthetase inhibitor Ridogrel.
    Heinisch G; Holzer W; Kunz F; Langer T; Lukavsky P; Pechlaner C; Weissenberger H
    J Med Chem; 1996 Sep; 39(20):4058-64. PubMed ID: 8831771
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of terbogrel on platelet function and prostaglandin endoperoxide transfer.
    Muck S; Weber AA; Schrör K
    Eur J Pharmacol; 1998 Feb; 344(1):45-8. PubMed ID: 9570446
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antithrombotic activity of the phosphodiesterase III inhibitor pelrinone in a canine model of coronary artery thrombosis: enhancement of efficacy with concurrent alpha 2-adrenergic antagonism.
    Kitzen JM; McCallum JD; Harvey C; Morin ME
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):777-90. PubMed ID: 1725888
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evidence for a role in thrombus stabilization for thromboxane A2 in human platelet deposition on collagen.
    Wagner WR; Hubbell JA
    J Lab Clin Med; 1992 Jun; 119(6):690-7. PubMed ID: 1534345
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dual inhibition of thromboxane A2 synthesis and thromboxane A2/prostaglandin endoperoxide receptors by ridogrel: anti-thrombotic effect in vivo in rat mesenteric arteries.
    Bourgain RH; Andries R; Decuyper K; De Clerck F
    J Lipid Mediat; 1991; 3(1):3-11. PubMed ID: 1837488
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.
    Noguchi K; Matsuzaki T; Shiroma N; Ojiri Y; Sakanashi M
    Br J Pharmacol; 1996 Jun; 118(4):941-50. PubMed ID: 8799566
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of thromboxane A2 in a microcirculation disorder of the rat inner ear.
    Umemura K; Asai Y; Uematsu T; Nakashima M
    Eur Arch Otorhinolaryngol; 1993; 250(6):342-4. PubMed ID: 8260145
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of the effects of anti-thromboxane agents in platelet-vessel wall interaction.
    Buccellati C; Ciceri P; Ballerio R; Casagrande C; Folco G; Nicosia S
    Eur J Pharmacol; 2002 May; 443(1-3):133-41. PubMed ID: 12044803
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetic and pharmacodynamic properties of FK070 (KDI-792), a novel thromboxane receptor antagonist/thromboxane synthetase inhibitor, after single and multiple oral administrations to healthy volunteers.
    Uematsu T; Kosuge K; Umemura K; Nakano M; Terakawa M; Nakashima M
    J Pharm Pharmacol; 1996 Apr; 48(4):380-5. PubMed ID: 8794987
    [TBL] [Abstract][Full Text] [Related]  

  • 77. "In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets.
    Berrettini M; De Cunto M; Parise P; Grasselli S; Nenci GG
    Eur J Clin Pharmacol; 1990; 39(5):495-500. PubMed ID: 1963845
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury.
    Mickelson JK; Hoff PT; Homeister JW; Fantone JC; Lucchesi BR
    J Am Coll Cardiol; 1993 Feb; 21(2):502-10. PubMed ID: 8426017
    [TBL] [Abstract][Full Text] [Related]  

  • 79. R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin.
    Hoet B; Falcon C; De Reys S; Arnout J; Deckmyn H; Vermylen J
    Blood; 1990 Feb; 75(3):646-53. PubMed ID: 2153424
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Roles of platelet-activating factor, thromboxane A2, ADP and thrombin in thrombogenesis in the guinea pig.
    Hirata Y; Takiguchi Y; Wada K; Matsuno H; Umemura K; Uematsu T; Nakashima M
    Eur J Pharmacol; 1993 Feb; 231(3):421-5. PubMed ID: 8449234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.